AstronauTx has ppointed Michelle Mellion (pictured) as Chief Medical Officer (CMO) and Deb Gouveia as Vice President, ...

Three symposia. A third year of Fellows. AI live on the booth floor. Medscape Oncology arrives at ASCO 2026 (Booth #10099) ...

Amgen and UCB’s novel osteoporosis treatment Evenity has been approved by the FDA, nearly two years after it was first submitted. Evenity (romosozumab) is a first-in-class antibody treatment that ...

Zeno is strengthening its European healthcare capabilities with the appointment of Cendrine Seror as Head of Health, Europe.

Eli Lilly and UNICEF USA have announced a collaboration aiming to improve non-communicable disease (NCD) prevention and care ...

AbbVie has appointed Kelly Sanderson Schrems as Vice President and General Manager, UK. Sanderson Schrems succeeds Steve ...

Boehringer Ingelheim and Immunitas Therapeutics have announced a global licensing agreement for a preclinical antibody programme being developed for chronic inflammatory and autoimmune diseases.

Mental health providers revealed years ago what healthcare is only now beginning to recognise: information alone does not ...

OVID Health has appointed Davide Scalenghe as Head of Global Strategy & Partnerships. In his new role, Scalenghe will focus on expanding the agency’s international footprint across public affairs, ...

Novartis has started construction on its new 46,000 sq. ft radioligand therapy (RLT) manufacturing site in Denton, Texas, the ...

The energy is building as we prepare to head to New Orleans, LA, for the annual scientific sessions of the American Diabetes ...